• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体治疗 - 诱导的大鼠尿路感染。

Bacteriophage therapy for -induced urinary tract infection in rats.

机构信息

Amity Institute of Microbial Technology, Amity University Rajasthan, Jaipur, Rajasthan, India.

Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India.

出版信息

Future Microbiol. 2023 Apr;18:323-334. doi: 10.2217/fmb-2022-0107. Epub 2023 May 4.

DOI:10.2217/fmb-2022-0107
PMID:37140267
Abstract

The present study evaluates the efficacy of bacteriophage therapy for urinary tract infection (UTI) in rats. UTI was established by inoculating (100 μl) at a concentration of 1.5 × 10 CFU/ml per urethra via a cannula in different groups of rats. For treatment, phage cocktails (200 μl) were administered at varying concentrations of 1 × 10 PFU/ml, 1 × 10 PFU/ml and 1 × 10 PFU/ml. The two doses of phage cocktail at the first two concentrations resulted in the cure of UTI. However, the lowest concentration of the phage cocktail warranted more doses to eradicate the causative bacteria. The quantity, frequency and safety of doses could be optimized in a rodent model using the urethral route.

摘要

本研究评估了噬菌体疗法治疗大鼠尿路感染(UTI)的疗效。通过在不同组大鼠的尿道中插入套管,以 1.5×10 CFU/ml 的浓度接种(100 μl),建立 UTI。为了进行治疗,以 1×10 PFU/ml、1×10 PFU/ml 和 1×10 PFU/ml 的不同浓度给予噬菌体鸡尾酒(200 μl)。前两种浓度的两种噬菌体鸡尾酒剂量导致 UTI 治愈。然而,最低浓度的噬菌体鸡尾酒需要更多剂量才能根除致病细菌。通过尿道途径在啮齿动物模型中可以优化剂量的数量、频率和安全性。

相似文献

1
Bacteriophage therapy for -induced urinary tract infection in rats.噬菌体治疗 - 诱导的大鼠尿路感染。
Future Microbiol. 2023 Apr;18:323-334. doi: 10.2217/fmb-2022-0107. Epub 2023 May 4.
2
A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model.一种新型噬菌体鸡尾酒疗法治疗小鼠尿路感染模型。
Arch Razi Inst. 2021 Nov 30;76(5):1229-1236. doi: 10.22092/ari.2021.356004.1762. eCollection 2021 Nov.
3
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.噬菌体抗性伴随尿路致病性大肠埃希菌在尿路环境中适应性降低。
mSphere. 2022 Aug 31;7(4):e0034522. doi: 10.1128/msphere.00345-22. Epub 2022 Aug 3.
4
Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.分离和鉴定新型溶菌噬菌体感染多药耐药大肠杆菌。
Microbiol Spectr. 2022 Feb 23;10(1):e0167821. doi: 10.1128/spectrum.01678-21. Epub 2022 Feb 16.
5
Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.噬菌体鸡尾酒疗法及噬菌体与抗生素协同作用有望成为控制多重耐药性尿路致病性大肠杆菌的传统抗生素替代方案。
Virus Res. 2021 Sep;302:198496. doi: 10.1016/j.virusres.2021.198496. Epub 2021 Jun 25.
6
|Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.新型噬菌体的分离与鉴定作为治疗大肠埃希菌尿路感染的潜在治疗选择。
Appl Microbiol Biotechnol. 2021 Jul;105(13):5617-5629. doi: 10.1007/s00253-021-11432-6. Epub 2021 Jul 12.
7
Evaluation of bacteriophage cocktail on urinary tract infection caused by colistin-resistant Klebsiella pneumoniae in mice model.噬菌体鸡尾酒疗法对小鼠模型中耐黏菌素肺炎克雷伯菌引起的尿路感染的评估。
J Glob Antimicrob Resist. 2024 Dec;39:41-53. doi: 10.1016/j.jgar.2024.07.019. Epub 2024 Aug 18.
8
Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains.鉴定感染多重耐药性尿路致病性大肠杆菌的噬菌体。
Arch Virol. 2024 Jun 8;169(7):142. doi: 10.1007/s00705-024-06063-x.
9
Discovery and characterisation of new phage targeting uropathogenic Escherichia coli.新型靶向尿路致病性大肠杆菌噬菌体的发现与鉴定
Virology. 2024 Sep;597:110148. doi: 10.1016/j.virol.2024.110148. Epub 2024 Jun 20.
10
Isolation and characterization of bacteriophages against E.coli urinary tract infection and evaluating their anti-biofilm activity and antibiotic synergy.分离和鉴定针对大肠杆菌尿路感染的噬菌体,并评估其抗生物膜活性和抗生素协同作用。
Microb Pathog. 2024 Aug;193:106789. doi: 10.1016/j.micpath.2024.106789. Epub 2024 Jul 6.

引用本文的文献

1
Treatment of Infections with T4-Related Bacteriophages Belonging to Class : Selecting Phage on the Basis of Their Generalized Transduction Capability.属于类的T4相关噬菌体感染的治疗:基于其广义转导能力选择噬菌体
Viruses. 2025 May 14;17(5):701. doi: 10.3390/v17050701.
2
The rise, fall, and resurgence of phage therapy for urinary tract infection.用于治疗尿路感染的噬菌体疗法的兴衰与复兴
EcoSal Plus. 2024 Dec 12;12(1):eesp00292023. doi: 10.1128/ecosalplus.esp-0029-2023. Epub 2024 Jan 11.
3
Uropathogenic (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment.
尿路致病性大肠杆菌(UPEC)相关的尿路感染:有效治疗面临挑战的分子基础
Microorganisms. 2023 Aug 28;11(9):2169. doi: 10.3390/microorganisms11092169.